Life Insurance
Consensus Index

AI Consensus Fit Review

Legal & General America Life Insurance After a Stroke Fit Review

Legal & General America is a mixed fit for Life Insurance After a Stroke.

Research: 2026-09-227 usable platform responsesRead the methodology ↗

Share

Answer Capsule

Legal & General America is a mixed fit for Life Insurance After a Stroke. Two of seven platforms named it during the ranking stage, and it ranked first on Perplexity and second on Google. Its strongest advantage is impaired-risk pricing: substandard table ratings are calculated from Standard Plus rates rather than Standard rates, which can lower premiums for rated applicants [1]. The main limitation is that stroke-specific U.S. underwriting rules, postponement periods, and post-stroke premiums are not publicly disclosed, and a stroke history disqualifies applicants from accelerated exam-free underwriting [3]. Buyers should obtain informal underwriting through an independent broker before applying.

Research Snapshot

FieldFinding
Platform mentions in ranking stage2 of 7 platforms (google, perplexity)
Share of included platform responses28.6%
Average listed rank1.5
Best listed rank1 (Perplexity)
Relevant product/model/planOPTerm level-premium term life; Life Step Universal Life; issued through Banner Life Insurance Company or William Penn Life Insurance Company of New York
Overall use-case fitMixed — credible option for medically stable, remote strokes; unverified for recent or severe strokes
Research date2026-09-22

Questions This Section Answers

  • Is Legal & General America a good choice for life insurance after a stroke?
  • Why did Legal & General America qualify for this stroke life insurance study when only two platforms named it?

Legal & General America qualified because two platforms named it during ranking discovery and both placed it near the top: Perplexity ranked it first and Google ranked it second, producing an average listed rank of 1.5. That is a small share of the seven included platform responses, so the ranking signal is narrow rather than broad.

The entity also qualified on substance. Legal & General America sells OPTerm, a level-premium renewable and convertible term product with 10-, 15-, 20-, 25-, 30-, 35-, and 40-year terms subject to issue-age and state limits [5]. It permits substandard classifications for more serious medical conditions, with table-rated premiums based on the Standard Plus underwriting class [5]. It also offers Life Step Universal Life, a permanent option, though it does not sell whole life or indexed universal life [7].

Financial strength was cited by independent reviewers: an A+ (Superior) rating from A.M. Best [9]. Coverage is issued by Banner life insurance Company in 49 states and the District of Columbia, and by William Penn Life Insurance Company of New York exclusively in New York [10].

This review sits inside a broader comparison of Life Insurance After a Stroke, where other carriers are evaluated on the same criteria.

The Product, Model, Plan, or Service Most Relevant to Life Insurance After a Stroke

Questions This Section Answers

  • Which Legal & General America plan should a buyer choose after a stroke: OPTerm term life or Life Step Universal Life?
  • Does Legal & General America's OPTerm term life allow conversion to permanent coverage after a stroke without a new medical exam?

OPTerm is the most relevant product for a stroke survivor who wants straightforward death-benefit protection. It is renewable and convertible term life insurance with a level death benefit during the selected initial term, available in 10- to 40-year terms depending on issue age and state [12]. Coverage amounts range from $100,000 up to $10 million depending on issue age and term length [13].

The conversion feature matters after a stroke. OPTerm can be converted during the guaranteed level-premium period or until attained age 70, whichever comes first; policies issued at age 66 or older have a five-year conversion period [12]. Independent reviews state conversion to universal life occurs without new medical exams or underwriting [15]. Conversion terms and available permanent products should be confirmed in the issued policy.

Life Step Universal Life is the permanent alternative, described as offering lifetime coverage to age 121 [17]. It is not an indexed universal life product and should not be confused with one [18].

Issue ages vary by term: OPTerm 10 is available to ages 20–75 across all classes, OPTerm 15 to ages 20–75, and OPTerm 20 to ages 20–70 for non-tobacco classes and 20–65 for tobacco classes [19]. One independent review states Legal & General offers term policies for clients as old as 95, twenty years later than most competitors [22].

What the AI Platforms Agreed About

Questions This Section Answers

  • What do AI platforms agree on about Legal & General America for a stroke survivor's life insurance?
  • Is Legal & General America's substandard pricing actually better than other carriers for rated stroke applicants?

Platforms agreed on several points, though the agreement was not unanimous across all seven.

Substandard pricing basis. Multiple platforms converged on the claim that Legal & General America calculates substandard table-rated premiums from Standard Plus rates rather than Standard rates, producing more competitive rated premiums [23]. Company material supports the Standard Plus basis [24].

Stroke history blocks accelerated underwriting. Company material states that a history of cerebral vascular disease such as stroke or TIA excludes applicants from accelerated exam-free underwriting [25]. Perplexity separately noted that applicants with major medical conditions may be disqualified from exam-free paths [26]. This is one of the clearer points of agreement.

An Attending Physician's Statement is required. Company field-guide material indicates an APS is typically required at all ages and amounts for cerebral vascular disease including hemorrhage, stroke, or TIA [27].

Postponement applies immediately after a stroke. Independent sources describe a postponement window after the event. One source states Banner Life treats a stroke within the last 6 months as a decline-or-postpone trigger [28], and another states stroke/TIA is postponed if within 6 months and table rated after that [29]. Industry-wide, most insurers require six to 12 months before accepting an application [30].

Individualized underwriting. Legal & General America's U.S. underwriting guide states it underwrites individuals rather than impairments and decides using the entirety of the information received [31].

Where the AI Platforms Disagreed or Were Uncertain

Questions This Section Answers

  • How long after a stroke must a buyer wait before Legal & General America will consider an application?
  • What table rating should a stroke survivor expect from Legal & General America, and is that rating publicly documented?

Fit ratings diverged. Google and Anthropic rated Legal & General America a "good" fit; Grok and Kimi rated it "mixed"; OpenAI rated it "mixed"; DeepSeek and Perplexity rated it "uncertain." No platform rated it poor.

Postponement length is disputed. One source describes a 6-month postponement trigger [32]. Another states ischemic CVA coverage may be postponed 6–12 months and hemorrhagic CVA postponement typically lasts 12 months or longer [34]. Grok-reported broker material describes TIA at 12 months with Table 4, ischemic stroke at 24 months with Table 6 or higher, and hemorrhagic stroke declined within 5 years [36]. These timelines conflict and none is confirmed by company disclosure.

Expected table ratings are not disclosed. No platform found a published U.S. stroke underwriting table, minimum waiting period, acceptance rate, or typical rating [37]. One independent source states that as long as it has been more than 12 months since the stroke, the majority of people will qualify for traditional fully underwritten coverage at a table rating [39]. Another states Legal & General America is highly rated for TIA history and can offer Standard health classes after two years without residual symptoms [40].

Geography creates a documentation gap. A Legal & General stroke guide identifies factors such as stroke timing and number, cause, treatment or surgery, residual symptoms, activity restrictions, and associated cardiovascular symptoms, but that guide is published for Legal & General's U.K. business and is not confirmed as U.S. Legal & General America underwriting guidance [41].

Accelerated underwriting eligibility is contested. Perplexity cited a New York eligibility document that lists Stroke/TIA in an accelerated-underwriting context while stating no medical exams, labs, or APSs for qualified applicants [44]. Google cited company material stating cerebral vascular disease excludes applicants from accelerated underwriting [45]. These two company-sourced positions point in opposite directions and should be treated as unresolved.

Use-Case-Specific Features and Capabilities

Questions This Section Answers

  • What features does Legal & General America's OPTerm offer a stroke survivor who wants long-term level-premium coverage?
  • Can a stroke survivor use Legal & General America's Lab Lift program to avoid a new medical exam?

Term length flexibility. OPTerm offers 10-, 15-, 20-, 25-, 30-, 35-, and 40-year level terms subject to issue-age and state limits [46]. Long terms can match mortgage or family-obligation timelines.

Conversion without new underwriting. Conversion is available during the guaranteed level-premium period or until attained age 70, whichever comes first, with a five-year conversion period for policies issued at age 66 or older [46]. Independent reviews describe conversion to universal life without new medical exams [47].

Substandard class availability. OPTerm product information states substandard classifications may be available for more serious medical conditions, with table-rated premiums based on Standard Plus [46].

Lab Lift. Independent broker material states Banner Life offers a Lab Lift program that may use recent physician lab results in lieu of a new paramedical exam for all risk classes including substandard [50]. Whether this applies to a specific stroke history is not confirmed.

Digital application and accelerated underwriting. Company materials describe digital application and accelerated underwriting capabilities, including possible reductions in exams and attending-physician statements for eligible applicants [52]. Company material states accelerated underwriting is for ages 20–60 up to $4 million and ages 61–70 up to $500,000 of face amount, any term duration [53]. One independent source describes a Horizon no-exam path for ages 20–60 up to $5,000,000 [54]. Another states eligible applicants ages 20–50 seeking up to $3 million can receive a decision in as little as 24–48 hours [55]. These figures conflict and should be verified.

Benefit limitations. Two-year contestability and suicide provisions apply; the suicide period is one year in Colorado, Missouri, and North Dakota [46]. Policy forms, not marketing summaries, control exact provisions.

Pricing, Fees, Contracts, and Ongoing Costs

Questions This Section Answers

  • How much does Legal & General America's OPTerm cost per month for a stroke survivor, and what policy fees apply?
  • What happens to Legal & General America OPTerm premiums after the level term ends?

No applicant-specific premium can be verified for a stroke survivor. OPTerm premiums depend on underwriting class, tobacco status, face-amount band, issue age, term length, state, and payment frequency [56].

Published fees. OPTerm product information lists a $90 annual policy fee for Banner Life products and an $80 annual policy fee for William Penn products [56]. One platform reported a $60 annual policy fee included in quoted premiums. This is a direct conflict between sources and should be confirmed on the quote.

Payment factors. The published monthly EFT modal factor is 0.085; semi-annual is 0.51 and quarterly is 0.26, applied to the applicable premium [56].

Premium structure over time. Premiums are level for the initial term and increase annually afterward, with the product summary identifying age 95 for the referenced OPTerm specifications [56]. Coverage is renewable but not level-priced after the term.

Sample pricing. Public quote pages show sample OPTerm rates based on excellent health, specific ages, term lengths, and face amounts [58]. These samples are not representative for a post-stroke buyer. One platform reported that standard-class rates run roughly 10–15% below industry average for 20-, 30-, and 40-year terms, and that industry-standard table ratings add roughly 25–50% above standard rates. That figure is platform-reported and not independently verified.

Coverage bands. Premium rates vary by coverage amount: $100,000–$249,999, $250,000–$499,999, $500,000–$999,999, and $1,000,000 and above [60].

Contract terms. Two-year contestability and suicide provisions apply; conversion is time-limited; free-look, lapse, reinstatement, grace-period, and cancellation terms should be confirmed in the state-specific policy contract [56]. One platform reported a standard 30-day free-look period.

Possible additional costs. Costs associated with medical examinations, laboratory testing, medical-record retrieval, or attending-physician statements are not clearly disclosed in reviewed public materials; verify whether the applicant or insurer pays them [56]. Optional riders may add cost and are subject to availability, state approval, and underwriting [56].

Best Suited For

Questions This Section Answers

  • Who is Legal & General America's OPTerm best suited for after a stroke?
  • Is Legal & General America a good fit for a TIA survivor who wants standard-rate term life?

Legal & General America is best suited for stroke survivors who are medically stable and far enough past the event to clear underwriting. Platform-reported best-fit profiles include applicants whose stroke was sufficiently remote, medically stable, and otherwise insurable under fully underwritten term criteria.

Specific profiles platforms identified:

  • TIA (mini-stroke) two or more years out, fully resolved, with clean follow-up [61]
  • Ischemic stroke two to four or more years out with full recovery and controlled risk factors
  • Applicants ages 20–60 with well-controlled blood pressure and cholesterol and no other cardiac conditions
  • Buyers seeking long-duration level-premium coverage of 20–40 years with conversion rights
  • Applicants who value conversion to permanent universal life without new medical underwriting before age 70
  • Buyers willing to complete full medical underwriting including a possible attending physician statement

The common thread is insurability under fully underwritten criteria, not a stroke-specific program. Legal & General America does not market a dedicated stroke pathway.

Probably Not Best Suited For

Questions This Section Answers

  • Who should not choose Legal & General America for life insurance after a stroke?
  • Will Legal & General America decline a stroke survivor who needs coverage within six months of the event?

Legal & General America is probably not the right choice for several buyer profiles.

  • Applicants needing guaranteed approval or coverage immediately after a recent stroke
  • Applicants whose stroke occurred within roughly 6 to 12 months, who typically face postponement [62]
  • Hemorrhagic stroke survivors, who typically face 12 months or longer postponement before consideration [65]
  • Applicants with significant residual impairment, recurrent cerebrovascular events, unresolved cause, or multiple uncontrolled cardiovascular risk factors
  • Applicants with multiple full strokes or multiple TIAs, where declination likelihood is high
  • Applicants seeking guaranteed-issue coverage, since Legal & General America's final expense guaranteed acceptance is limited to ages 50–80
  • Applicants who want published, upfront stroke-specific underwriting guidelines before applying
  • Applicants who cannot tolerate a possible medical exam, records review, or decline risk
  • Applicants seeking whole life or indexed universal life, neither of which Legal & General America offers [66]

When Another Option May Be Better

Questions This Section Answers

  • What is a better alternative to Legal & General America for a stroke survivor who needs guaranteed-issue coverage?
  • When should a stroke survivor choose a specialty impaired-risk carrier instead of Legal & General America?

Another option may be better in these situations:

Guaranteed issue or simplified issue is needed. If the buyer needs guaranteed approval or coverage immediately after a recent stroke, or needs guaranteed-issue or simplified-issue coverage and accepts lower limits, higher premiums, or graded benefits, a different carrier is likely more appropriate. One platform named Mutual of Omaha for guaranteed issue.

The stroke was recent, severe, or recurrent. If the stroke was recent, recurrent, unexplained, or accompanied by substantial residual symptoms, a specialty broker may identify carriers with more favorable impaired-risk guidelines. Platforms named Prudential and John Hancock as potentially more lenient for recent or hemorrhagic strokes, and Protective Life for borderline permanent coverage. These are platform-reported suggestions, not verified underwriting positions.

Published stroke guidelines are required. If the buyer wants published stroke underwriting guidelines before applying, or would benefit from a brokerage comparing multiple insurers' impaired-risk appetites, another route is better.

Permanent lifetime coverage is required. If the buyer needs permanent coverage rather than term, and does not want to rely on conversion, another carrier may be better.

Stroke-specific benefit structures are wanted. Specialty products such as Liberty Bankers Life's Heart & Stroke Plus offer explicit stroke lump-sum benefits up to $75,000, recurrence benefit schedules, simplified issue, and a 30-day waiting period [68]. Legal & General America's traditional products do not match these structures.

A better rating is available elsewhere. If another carrier's informal underwriting indicates a better rating or acceptance outcome for the buyer's exact stroke history, that carrier should be chosen.

Buyers comparing across the broader life insurance market should weigh these alternatives against Legal & General America's substandard pricing basis rather than assuming the lowest headline rate wins.

Questions to Verify Before Buying

Questions This Section Answers

  • What should a buyer confirm with Legal & General America before signing a stroke-related life insurance contract?

  • Which issuing company will write the Legal & General America policy in the buyer's state?

  • Which U.S. issuing company will write the policy in the buyer's state: Banner Life or William Penn?

  • Will the buyer's exact stroke history be considered for OPTerm, and is there a minimum time since stroke or TIA before consideration?

  • How will the underwriter evaluate stroke type, cause, imaging, treatment, recurrence history, residual symptoms, functional status, medications, blood pressure, atrial fibrillation, diabetes, cholesterol, smoking, and other cardiovascular risks?

  • Can the broker obtain an anonymous or informal underwriting indication before submitting a formal application?

  • Will a paramedical examination, neurological records, imaging, hospital records, cardiology records, or attending-physician statement be required, and who pays any related costs?

  • What underwriting class, table rating, flat extra, postponement period, or coverage limit is being offered?

  • What is the guaranteed premium during the selected term, what are the post-term renewal premiums, and what annual policy fee applies?

  • What exact conversion rights apply, including the deadline, eligible permanent products, conversion charges, and whether new medical underwriting is waived?

  • Are the accelerated death benefit, waiver-of-premium, and other riders available in the buyer's state and compatible with the offered policy?

  • What are the state-specific contestability, suicide, grace-period, lapse, reinstatement, free-look, and cancellation provisions?

  • Should the buyer compare this offer with at least two other carriers using the same application facts before accepting or replacing existing coverage?

  • Does the buyer's stroke history qualify for accelerated underwriting, or will full underwriting be required?

  • Will Legal & General America accept medical records from the buyer's cardiologist and neurologist, or require examination by its own physicians?

Final AI Consensus Verdict

Legal & General America is a mixed fit for life insurance after a stroke. Two of seven platforms named it during ranking discovery, and both placed it near the top, but the fit ratings split across "good," "mixed," and "uncertain" with no platform rating it poor.

The strongest case for considering it is impaired-risk pricing: substandard table ratings are calculated from Standard Plus rates rather than Standard rates, which can reduce premiums for rated applicants [69]. OPTerm also offers long level terms up to 40 years and conversion to universal life without new medical underwriting before age 70 [71].

The strongest case against relying on it is disclosure. No platform found a published U.S. stroke underwriting table, minimum waiting period, acceptance rate, or typical rating [73]. A stroke history excludes applicants from accelerated exam-free underwriting per company material [75], and an attending physician's statement is typically required [76]. Postponement timelines conflict across sources, ranging from 6 months to 24 months or longer depending on stroke type [77].

The practical verdict: Legal & General America is worth investigating for a stroke survivor whose event is remote and medically stable, but it is not a clearly superior or stroke-specialist choice. Obtain an informal underwriting assessment through an independent broker and compare carrier-specific offers before applying formally.

How This Review Was Produced

This review was produced from a structured multi-platform research run dated 2026-09-22. Seven AI platforms evaluated Legal & General America for the specific use case of life insurance after a stroke: OpenAI (gpt-5.6-luna), Anthropic (claude-haiku-4-5-20251001), Google (gemini-3.5-flash), Grok (x-ai/grok-4.3), Kimi (moonshotai/kimi-k2.6), Perplexity (perplexity/sonar), and DeepSeek (deepseek-v4-flash).

Each platform returned a fit rating, a direct answer, strengths, limitations, pricing and terms, use-case findings, and questions to verify before buying. Two platforms named Legal & General America during the ranking stage; all seven evaluated fit. Platform outputs were normalized, deduplicated, and checked for factual conflicts. Citations are platform-reported evidence and were not independently verified by the writer stage. No personal testing, customer experience, or independent verification was performed.

Methodology Limitations

  • Platform-reported research dates differ from the authoritative run date of 2026-09-22. DeepSeek reported 2026-06-15; the other six platforms reported 2026-09-23. These are provenance metadata and do not independently prove freshness.
  • All included platforms evaluated fit, but the platform mention count reflects only platforms that named the entity during ranking discovery.
  • The supplied URLs were collected from platform responses and were not independently validated.
  • The official website supplied for the entity, legalandgeneralamerica.com, failed DNS resolution during retrieval and could not be corroborated. Product documents reviewed were hosted at lgamerica.com and bannerlife.com. Verify the official domain and issuing entity before applying.
  • The stroke-specific Legal & General guide reviewed is from the U.K. business and should not be treated as proof of U.S. Legal & General America underwriting rules.
  • The U.S. field guide is a broker reference and states that actual decisions may be more or less favorable than the guide; it is not a consumer eligibility guarantee.
  • Current applicant-specific premiums, stroke waiting periods, and likely underwriting class were not publicly verifiable.
  • Reviewed product documents show publication or revision dates from 2025 or earlier; confirm documents and rates remain current on the application date.
  • DeepSeek ran without search enabled, so its output reflects model knowledge rather than retrieved evidence and should be weighted accordingly.
  • Conflicting figures appear across sources for the annual policy fee ($60 vs. $80/$90), accelerated underwriting limits ($4M vs. $5M), and postponement timelines (6 months vs. 12–24 months). These conflicts are disclosed rather than resolved.
  • No claim in this review should be read as establishing that AI-platform agreement proves product quality.

Sources

Company-Owned Sources

Independent Sources

Verify this research

Check when the research was run, which platforms were included, and what supports the findings.

Study date
September 22, 2026
Platforms analyzed
7
Source records
47
Ranking mentions
2 of 7
Platform share
29%
Final consensus rank
#10

Behind the findings

Platforms in this study

  • ChatGPT
  • Claude
  • DeepSeek
  • Grok
  • Perplexity
  • Kimi
  • Gemini

Source records

28 independent · 19 company-owned

Evidence support

38 direct · 8 partial

Keep in mind

Use the run research_date as the study date. Platform-reported dates are provenance metadata and do not independently prove freshness.

Technical verification details

Use this SHA-256 fingerprint to identify the source snapshot associated with this study.

bd046be51152c8247fd54057c98550d566912775fb7223119059cf6f3e8a5be2